0 XP   0   0   0

Karo Pharma SA










Financial Health of Karo Pharma SA




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings  


Richest
#106 / 673

Total Sales
#183 / 673

Making Money
#549 / 673

Working Efficiently
#409 / 673

Karo Pharma SA
Buy, Hold or Sell?

Should you buy, hold or sell Karo Pharma SA?

I guess you are interested in Karo Pharma SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Karo Pharma SA

Let's start. I'm going to help you getting a better view of Karo Pharma SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Karo Pharma SA even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Karo Pharma SA is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Karo Pharma SA. The closing price on 2022-11-24 was kr60.70 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Karo Pharma SA Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Karo Pharma SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Karo Pharma SA earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -7.2% means that kr-0.07 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Karo Pharma SA:

  • The MRQ is -7.2%. The company is making a loss. -1
  • The TTM is -3.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-3.3%-3.8%
TTM-3.3%YOY0.1%-3.4%
TTM-3.3%5Y7.2%-10.6%
5Y7.2%10Y7.6%-0.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%0.4%-7.6%
TTM-3.3%0.3%-3.6%
YOY0.1%0.2%-0.1%
5Y7.2%-0.7%+7.9%
10Y7.6%-0.1%+7.7%
1.1.2. Return on Assets

Shows how efficient Karo Pharma SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • -0.8% Return on Assets means that Karo Pharma SA generated kr-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Karo Pharma SA:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-0.3%-0.5%
TTM-0.3%YOY0.0%-0.3%
TTM-0.3%5Y0.5%-0.8%
5Y0.5%10Y0.8%-0.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%0.1%-0.9%
TTM-0.3%0.1%-0.4%
YOY0.0%-0.1%+0.1%
5Y0.5%-0.2%+0.7%
10Y0.8%0.1%+0.7%
1.1.3. Return on Equity

Shows how efficient Karo Pharma SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • -1.7% Return on Equity means Karo Pharma SA generated kr-0.02 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Karo Pharma SA:

  • The MRQ is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-0.6%-1.1%
TTM-0.6%YOY0.0%-0.6%
TTM-0.6%5Y0.9%-1.5%
5Y0.9%10Y1.5%-0.6%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.7%0.6%-2.3%
TTM-0.6%0.4%-1.0%
YOY0.0%0.4%-0.4%
5Y0.9%-0.3%+1.2%
10Y1.5%0.1%+1.4%

1.2. Operating Efficiency of Karo Pharma SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Karo Pharma SA is operating .

  • Measures how much profit Karo Pharma SA makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.1% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Karo Pharma SA:

  • The MRQ is 0.1%. The company is operating inefficient. -1
  • The TTM is 1.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ0.1%TTM1.4%-1.3%
TTM1.4%YOY9.1%-7.7%
TTM1.4%5Y16.4%-15.0%
5Y16.4%10Y9.3%+7.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.5%-2.4%
TTM1.4%1.6%-0.2%
YOY9.1%2.7%+6.4%
5Y16.4%1.8%+14.6%
10Y9.3%0.8%+8.5%
1.2.2. Operating Ratio

Measures how efficient Karo Pharma SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.43 means that the operating costs are kr0.43 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Karo Pharma SA:

  • The MRQ is 0.434. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.811. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.434TTM0.811-0.377
TTM0.811YOY1.366-0.556
TTM0.8115Y1.197-0.386
5Y1.19710Y0.758+0.440
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4341.473-1.039
TTM0.8111.456-0.645
YOY1.3661.398-0.032
5Y1.1971.374-0.177
10Y0.7581.191-0.433

1.3. Liquidity of Karo Pharma SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Karo Pharma SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.71 means the company has kr2.71 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Karo Pharma SA:

  • The MRQ is 2.714. The company is able to pay all its short-term debts. +1
  • The TTM is 2.073. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.714TTM2.073+0.641
TTM2.073YOY0.326+1.747
TTM2.0735Y1.011+1.062
5Y1.01110Y0.649+0.362
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7141.880+0.834
TTM2.0731.901+0.172
YOY0.3262.112-1.786
5Y1.0112.182-1.171
10Y0.6491.891-1.242
1.3.2. Quick Ratio

Measures if Karo Pharma SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 1.73 means the company can pay off kr1.73 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Karo Pharma SA:

  • The MRQ is 1.735. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.200. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.735TTM1.200+0.535
TTM1.200YOY0.196+1.004
TTM1.2005Y0.319+0.881
5Y0.31910Y0.200+0.119
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7350.733+1.002
TTM1.2000.796+0.404
YOY0.1960.808-0.612
5Y0.3190.834-0.515
10Y0.2000.821-0.621

1.4. Solvency of Karo Pharma SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Karo Pharma SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Karo Pharma SA to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55 means that Karo Pharma SA assets are financed with 55.3% credit (debt) and the remaining percentage (100% - 55.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Karo Pharma SA:

  • The MRQ is 0.553. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.544. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.553TTM0.544+0.010
TTM0.544YOY0.550-0.006
TTM0.5445Y0.523+0.021
5Y0.52310Y0.452+0.071
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5530.437+0.116
TTM0.5440.424+0.120
YOY0.5500.398+0.152
5Y0.5230.398+0.125
10Y0.4520.401+0.051
1.4.2. Debt to Equity Ratio

Measures if Karo Pharma SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 124.0% means that company has kr1.24 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Karo Pharma SA:

  • The MRQ is 1.240. The company is able to pay all its debts with equity. +1
  • The TTM is 1.192. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.240TTM1.192+0.048
TTM1.192YOY1.221-0.029
TTM1.1925Y1.130+0.062
5Y1.13010Y0.920+0.210
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2400.652+0.588
TTM1.1920.675+0.517
YOY1.2210.623+0.598
5Y1.1300.684+0.446
10Y0.9200.697+0.223

2. Market Valuation of Karo Pharma SA

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Karo Pharma SA generates.

  • Above 15 is considered overpriced but always compare Karo Pharma SA to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -195.13 means the investor is paying kr-195.13 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Karo Pharma SA:

  • The EOD is -235.940. Company is losing money. -2
  • The MRQ is -195.127. Company is losing money. -2
  • The TTM is -75.241. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-235.940MRQ-195.127-40.813
MRQ-195.127TTM-75.241-119.885
TTM-75.241YOY-1,970.906+1,895.665
TTM-75.2415Y-679.615+604.374
5Y-679.61510Y-178.565-501.050
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-235.940-0.124-235.816
MRQ-195.127-0.437-194.690
TTM-75.241-0.102-75.139
YOY-1,970.90615.340-1,986.246
5Y-679.6157.916-687.531
10Y-178.5657.700-186.265

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Karo Pharma SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 1.66 means the investor is paying kr1.66 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Karo Pharma SA:

  • The EOD is 2.009. Good. +1
  • The MRQ is 1.661. Good. +1
  • The TTM is 2.395. Good. +1
Trends
Current periodCompared to+/- 
EOD2.009MRQ1.661+0.347
MRQ1.661TTM2.395-0.734
TTM2.395YOY2.732-0.337
TTM2.3955Y3.207-0.811
5Y3.20710Y7.847-4.641
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.0091.415+0.594
MRQ1.6611.586+0.075
TTM2.3952.019+0.376
YOY2.7322.230+0.502
5Y3.2071.895+1.312
10Y7.8471.505+6.342
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Karo Pharma SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--8.9412.227+301%0.166+5293%1.317+579%0.752+1089%
Book Value Growth--0.9320.911+2%0.905+3%0.912+2%0.907+3%
Book Value Per Share--30.21923.580+28%20.928+44%16.852+79%8.931+238%
Book Value Per Share Growth--0.2960.074+302%0.008+3686%0.083+257%0.025+1061%
Current Ratio--2.7142.073+31%0.326+733%1.011+168%0.649+318%
Debt To Asset Ratio--0.5530.544+2%0.550+1%0.523+6%0.452+22%
Debt To Equity Ratio--1.2401.192+4%1.221+2%1.130+10%0.920+35%
Dividend Per Share--0.0050.0050%-+100%0.034-85%0.028-83%
Dividend Per Share Growth---0.250-100%--0.083-100%0.146-100%
Eps---0.257-0.174-33%0.002-15018%0.104-348%0.065-496%
Eps Growth---0.089-100%-3.2730%-1.3870%-1.0530%
Gross Profit Margin--1.0000.750+33%1.0000%0.950+5%0.625+60%
Net Profit Margin---0.072-0.033-53%0.001-6778%0.072-199%0.076-194%
Operating Margin--0.0010.014-93%0.091-99%0.164-99%0.093-99%
Operating Ratio--0.4340.811-47%1.366-68%1.197-64%0.758-43%
Pb Ratio2.009+17%1.6612.395-31%2.732-39%3.207-48%7.847-79%
Pe Ratio-235.940-21%-195.127-75.241-61%-1970.906+910%-679.615+248%-178.565-8%
Price Per Share60.700+17%50.20054.850-8%57.100-12%45.444+10%29.838+68%
Price To Total Gains Ratio6.785+17%5.6122734.574-100%126.296-96%619.608-99%210.104-97%
Profit Growth---100.000-33.919-66%-76.595-23%-10.019-90%14.221-803%
Quick Ratio--1.7351.200+45%0.196+783%0.319+444%0.200+769%
Return On Assets---0.008-0.003-62%0.000-17030%0.005-252%0.008-194%
Return On Equity---0.017-0.006-62%0.000-31454%0.009-289%0.015-214%
Revenue Growth--1.0000.937+7%0.906+10%0.915+9%0.871+15%
Total Gains Per Share--8.9462.232+301%0.166+5296%1.351+562%0.780+1047%
Total Gains Per Share Growth--0.99913.318-92%-1.040+204%-3.187+419%-11.140+1215%
Usd Book Value--791884660.000617905277.500+28%548417120.475+44%441601350.925+79%234033432.168+238%
Usd Book Value Change Per Share--0.8570.214+301%0.016+5293%0.126+579%0.072+1089%
Usd Book Value Per Share--2.8982.261+28%2.007+44%1.616+79%0.856+238%
Usd Dividend Per Share--0.0000.0000%-+100%0.003-85%0.003-83%
Usd Eps---0.025-0.017-33%0.000-15018%0.010-348%0.006-496%
Usd Price Per Share5.821+17%4.8145.260-8%5.476-12%4.358+10%2.861+68%
Usd Profit---13483540.000-4548057.500-66%45144.925-29967%2719321.220-596%1701237.230-893%
Usd Revenue--188472270.00083092555.000+127%68598900.300+175%56131137.895+236%29981387.223+529%
Usd Total Gains Per Share--0.8580.214+301%0.016+5296%0.130+562%0.075+1047%
 EOD+3 -2MRQTTM+18 -15YOY+19 -135Y+18 -1610Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Karo Pharma SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-235.940
Price to Book Ratio (EOD)Between0-12.009
Net Profit Margin (MRQ)Greater than0-0.072
Operating Margin (MRQ)Greater than00.001
Quick Ratio (MRQ)Greater than11.735
Current Ratio (MRQ)Greater than12.714
Debt to Asset Ratio (MRQ)Less than10.553
Debt to Equity Ratio (MRQ)Less than11.240
Return on Equity (MRQ)Greater than0.15-0.017
Return on Assets (MRQ)Greater than0.05-0.008
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Karo Pharma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.143
Ma 20Greater thanMa 5060.440
Ma 50Greater thanMa 10060.354
Ma 100Greater thanMa 20057.838
OpenGreater thanClose60.400
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets18,492,800
Total Liabilities10,235,400
Total Stockholder Equity8,257,400
 As reported
Total Liabilities 10,235,400
Total Stockholder Equity+ 8,257,400
Total Assets = 18,492,800

Assets

Total Assets18,492,800
Total Current Assets1,699,100
Long-term Assets1,699,100
Total Current Assets
Cash And Cash Equivalents 353,100
Net Receivables 732,900
Inventory 562,100
Total Current Assets  (as reported)1,699,100
Total Current Assets  (calculated)1,648,100
+/- 51,000
Long-term Assets
Property Plant Equipment 112,400
Intangible Assets 16,006,600
Other Assets 671,900
Long-term Assets  (as reported)16,793,700
Long-term Assets  (calculated)16,790,900
+/- 2,800

Liabilities & Shareholders' Equity

Total Current Liabilities626,000
Long-term Liabilities9,609,400
Total Stockholder Equity8,257,400
Total Current Liabilities
Short-term Debt 77,000
Short Long Term Debt 77,000
Accounts payable 201,800
Other Current Liabilities 37,400
Total Current Liabilities  (as reported)626,000
Total Current Liabilities  (calculated)393,200
+/- 232,800
Long-term Liabilities
Long term Debt Total 8,625,700
Other Liabilities 983,700
Long-term Liabilities  (as reported)9,609,400
Long-term Liabilities  (calculated)9,609,400
+/-0
Total Stockholder Equity
Common Stock109,300
Retained Earnings -451,500
Capital Surplus 8,484,800
Other Stockholders Equity 114,800
Total Stockholder Equity (as reported)8,257,400
Total Stockholder Equity (calculated)8,257,400
+/-0
Other
Capital Stock109,300
Cash And Equivalents353,100
Cash and Short Term Investments 353,100
Common Stock Shares Outstanding 273,255
Liabilities and Stockholders Equity 18,492,800
Net Debt 8,301,400
Net Invested Capital 16,911,900
Net Tangible Assets -7,749,200
Net Working Capital 1,073,100



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,343,469
945,699
794,288
688,326
505,718
350,422
332,439
229,027
191,909
161,622
129,593
214,131
219,892
173,402
136,594
374,815
329,122
300,714
291,896
251,972
192,955
545,859
492,791
453,572
399,912
351,141
306,971
263,189
214,657
170,160
132,019
255,837
203,361
162,730
128,836
409,482
324,675
258,348
209,465
171,500
134,566
86,387
64,439
77,737
59,656
45,294
46,265
40,291
27,641
89,285
77,956
60,621
40,957
45,604
276,323
642,537
602,167
743,782
766,459
1,772,846
1,787,965
1,749,126
1,759,886
4,141,848
3,674,778
6,897,058
7,029,256
6,884,639
7,013,801
7,040,798
10,999,151
10,898,530
11,842,030
12,451,921
12,401,027
12,517,499
12,687,500
13,199,400
12,923,000
12,593,400
0
18,492,800
18,492,800012,593,40012,923,00013,199,40012,687,50012,517,49912,401,02712,451,92111,842,03010,898,53010,999,1517,040,7987,013,8016,884,6397,029,2566,897,0583,674,7784,141,8481,759,8861,749,1261,787,9651,772,846766,459743,782602,167642,537276,32345,60440,95760,62177,95689,28527,64140,29146,26545,29459,65677,73764,43986,387134,566171,500209,465258,348324,675409,482128,836162,730203,361255,837132,019170,160214,657263,189306,971351,141399,912453,572492,791545,859192,955251,972291,896300,714329,122374,815136,594173,402219,892214,131129,593161,622191,909229,027332,439350,422505,718688,326794,288945,6991,343,469
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
290,736
345,750
327,802
346,942
1,124,554
606,728
739,649
868,848
912,071
1,021,143
1,106,046
1,123,941
1,175,059
1,381,102
1,394,895
1,496,136
1,731,048
1,907,300
1,852,700
1,757,700
1,491,292
1,699,100
1,699,100
1,699,1001,699,1001,491,2921,757,7001,852,7001,907,3001,731,0481,496,1361,394,8951,381,1021,175,0591,123,9411,106,0461,021,143912,071868,848739,649606,7281,124,554346,942327,802345,750290,73600000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,346
166,110
150,190
130,387
838,586
295,189
333,304
443,112
398,580
493,569
561,207
225,017
248,806
277,727
390,406
365,330
570,391
594,500
523,000
378,700
260,700
0
353,100
353,1000260,700378,700523,000594,500570,391365,330390,406277,727248,806225,017561,207493,569398,580443,112333,304295,189838,586130,387150,190166,110121,34600000000000000000000000000000000000000000000000000000000000
       Net Receivables 
15,021
9,855
16,486
3,001
0
4,878
0
9,925
0
0
0
7,142
0
0
0
8,880
0
0
0
6,192
0
0
0
6,356
0
0
0
6,148
0
0
0
7,948
0
0
0
3,993
0
0
0
4,128
0
0
0
17,119
0
0
0
9,515
0
0
0
2,268
0
0
0
40,062
0
0
0
89,140
0
0
0
173,847
0
0
0
309,215
0
0
0
515,458
0
0
0
702,143
736,300
744,400
854,000
718,974
732,900
732,900
732,900732,900718,974854,000744,400736,300702,143000515,458000309,215000173,84700089,14000040,0620002,2680009,51500017,1190004,1280003,9930007,9480006,1480006,3560006,1920008,8800007,1420009,92504,87803,00116,4869,85515,021
       Other Current Assets 
0
3,758
0
4,407
0
6,122
10,559
7,156
17,941
13,092
8,227
7,391
14,194
11,349
8,369
5,931
12,571
15,483
13,972
3,242
11,520
13,872
11,117
5,892
13,294
16,331
10,877
4,543
5,400
5,886
5,896
4,372
5,111
5,633
7,725
5,870
8,099
8,015
6,346
3,281
13,066
6,428
10,169
2,774
7,789
7,968
10,670
3,477
13,946
12,474
11,136
2,680
5,131
4,858
20,159
1,806
104,952
108,339
140,478
1,149
179,640
177,612
216,555
2,173
311,539
406,345
425,736
9,276
527,574
544,839
898,924
-50
1,103,375
1,004,489
1,130,806
5,509
0
200
0
9,410
0
0
009,410020005,5091,130,8061,004,4891,103,375-50898,924544,839527,5749,276425,736406,345311,5392,173216,555177,612179,6401,149140,478108,339104,9521,80620,1594,8585,1312,68011,13612,47413,9463,47710,6707,9687,7892,77410,1696,42813,0663,2816,3468,0158,0995,8707,7255,6335,1114,3725,8965,8865,4004,54310,87716,33113,2945,89211,11713,87211,5203,24213,97215,48312,5715,9318,36911,34914,1947,3918,22713,09217,9417,15610,5596,12204,40703,7580
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,992,658
5,934,751
9,875,211
9,723,471
10,460,928
11,057,026
10,904,891
10,786,451
10,780,200
11,346,700
11,165,300
11,102,126
0
16,793,700
16,793,700011,102,12611,165,30011,346,70010,780,20010,786,45110,904,89111,057,02610,460,9289,723,4719,875,2115,934,7515,992,65800000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
23,724
24,667
0
38,762
34,791
30,063
26,470
23,916
23,569
22,443
20,427
18,531
16,665
15,261
14,189
13,124
12,082
10,814
9,803
8,632
7,995
8,108
7,123
5,884
8,346
7,459
7,450
8,079
7,434
6,818
6,244
5,788
5,312
4,813
4,958
4,585
4,441
4,528
4,738
5,558
4,539
4,545
4,268
3,771
3,843
3,535
3,476
4,500
5,100
4,882
4,517
4,050
3,611
1,871
1,753
5,701
5,504
5,272
9,434
12,297
12,537
12,712
12,845
14,498
14,945
15,757
15,642
16,793
18,031
17,756
21,095
30,033
31,297
74,822
79,176
69,464
98,800
95,500
87,800
94,896
112,400
112,400
112,400112,40094,89687,80095,50098,80069,46479,17674,82231,29730,03321,09517,75618,03116,79315,64215,75714,94514,49812,84512,71212,53712,2979,4345,2725,5045,7011,7531,8713,6114,0504,5174,8825,1004,5003,4763,5353,8433,7714,2684,5454,5395,5584,7384,5284,4414,5854,9584,8135,3125,7886,2446,8187,4348,0797,4507,4598,3465,8847,1238,1087,9958,6329,80310,81412,08213,12414,18915,26116,66518,53120,42722,44323,56923,91626,47030,06334,79138,762024,66723,724
       Goodwill 
0
577,943
0
336,145
0
94,349
12,891
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
236,174
0
0
0
730,725
0
0
0
1,510,342
0
0
0
1,873,187
0
0
0
3,421,905
0
0
0
3,263,886
0
0
0
3,318,893
0
0
003,318,8930003,263,8860003,421,9050001,873,1870001,510,342000730,725000236,17400000000000000000000000000000000000000000000000012,89194,3490336,1450577,9430
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,357
9,465
136
216
136
76,974
492,765
560,829
136
136
288
17,825
2,745
0
0
0
0
0
0
0
0
0
0
00000000002,74517,825288136136560,829492,76576,9741362161369,46528,35700000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
938,707
578,453
485,687
359,858
234,027
108,197
21,806
3,983
1,517
131
104
78
51
24
0
0
0
0
0
0
0
3,428
3,140
2,851
2,563
2,275
1,986
1,698
1,409
1,121
833
545
256
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
122,326
475,655
480,471
472,506
468,694
1,431,393
1,420,213
1,408,476
1,399,882
2,922,201
2,976,131
5,648,887
5,583,937
3,549,759
5,441,306
5,385,531
9,254,873
5,668,189
9,854,561
10,410,756
10,257,684
10,029,478
10,005,500
10,575,200
10,397,500
10,342,400
0
16,006,600
16,006,600010,342,40010,397,50010,575,20010,005,50010,029,47810,257,68410,410,7569,854,5615,668,1899,254,8735,385,5315,441,3063,549,7595,583,9375,648,8872,976,1312,922,2011,399,8821,408,4761,420,2131,431,393468,694472,506480,471475,655122,3260000000000000000000002565458331,1211,4091,6981,9862,2752,5632,8513,1403,42800000002451781041311,5173,98321,806108,197234,027359,858485,687578,453938,707
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,992,658
5,934,751
9,875,211
1
10,460,928
0
0
2
0
0
0
0
0
100
1000000020010,460,92819,875,2115,934,7515,992,65800000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
51,431
44,620
85,405
130,643
112,034
81,362
64,892
54,177
50,275
44,274
37,785
35,179
43,392
32,192
26,755
38,267
28,711
25,431
28,380
41,469
33,883
66,367
43,882
59,309
57,488
58,629
56,309
43,715
41,081
33,413
29,476
40,678
28,666
26,525
27,071
66,934
29,824
40,712
42,906
55,578
72,686
47,125
37,817
31,820
24,408
24,628
19,080
16,452
17,180
16,689
15,270
19,714
15,395
21,587
36,778
277,956
234,608
122,147
139,332
1,055,834
683,591
687,267
685,783
2,555,333
1,798,034
3,239,491
3,378,281
3,273,638
3,309,216
3,327,326
7,299,506
5,256,621
6,251,969
6,809,724
6,773,076
6,879,009
6,902,800
7,376,000
7,036,100
6,779,100
0
10,235,400
10,235,40006,779,1007,036,1007,376,0006,902,8006,879,0096,773,0766,809,7246,251,9695,256,6217,299,5063,327,3263,309,2163,273,6383,378,2813,239,4911,798,0342,555,333685,783687,267683,5911,055,834139,332122,147234,608277,95636,77821,58715,39519,71415,27016,68917,18016,45219,08024,62824,40831,82037,81747,12572,68655,57842,90640,71229,82466,93427,07126,52528,66640,67829,47633,41341,08143,71556,30958,62957,48859,30943,88266,36733,88341,46928,38025,43128,71138,26726,75532,19243,39235,17937,78544,27450,27554,17764,89281,362112,034130,64385,40544,62051,431
   > Total Current Liabilities 
0
44,620
0
116,704
99,672
73,284
61,310
49,409
43,496
41,254
34,987
32,606
41,047
30,078
24,875
36,623
27,288
24,227
27,384
40,757
33,291
65,896
43,533
59,084
54,768
56,174
54,108
41,693
39,241
31,759
28,011
39,405
27,588
25,646
26,395
66,464
29,563
40,712
42,906
55,578
72,686
47,125
37,817
31,820
24,408
24,628
19,080
16,452
17,180
16,689
15,270
19,696
15,395
21,587
30,435
225,190
176,135
69,460
86,757
456,580
120,635
145,726
165,539
1,013,172
258,328
1,162,717
1,242,606
1,293,075
1,290,554
1,337,322
3,087,735
3,536,119
3,562,999
4,206,810
5,143,419
5,221,466
5,269,700
5,803,100
5,501,600
586,339
626,000
626,000
626,000626,000586,3395,501,6005,803,1005,269,7005,221,4665,143,4194,206,8103,562,9993,536,1193,087,7351,337,3221,290,5541,293,0751,242,6061,162,717258,3281,013,172165,539145,726120,635456,58086,75769,460176,135225,19030,43521,58715,39519,69615,27016,68917,18016,45219,08024,62824,40831,82037,81747,12572,68655,57842,90640,71229,56366,46426,39525,64627,58839,40528,01131,75939,24141,69354,10856,17454,76859,08443,53365,89633,29140,75727,38424,22727,28836,62324,87530,07841,04732,60634,98741,25443,49649,40961,31073,28499,672116,704044,6200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
915,500
626,124
631,873
165,539
816,069
258,328
1,162,717
1,242,606
1,070,143
1,290,554
1,337,322
3,087,735
3,090,429
0
0
0
0
4,796,900
5,310,500
5,002,900
74,345
0
77,000
77,000074,3455,002,9005,310,5004,796,90000003,090,4293,087,7351,337,3221,290,5541,070,1431,242,6061,162,717258,328816,069165,539631,873626,124915,50000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
915,500
626,124
631,873
165,539
816,069
258,328
1,162,717
1,242,606
1,070,143
1,290,554
1,337,322
3,087,735
3,090,429
0
0
0
4,707,573
4,796,900
5,310,500
5,002,900
74,345
0
77,000
77,000074,3455,002,9005,310,5004,796,9004,707,5730003,090,4293,087,7351,337,3221,290,5541,070,1431,242,6061,162,717258,328816,069165,539631,873626,124915,50000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
9,487
0
16,462
0
11,977
0
7,001
0
0
0
7,359
0
0
0
18,041
0
0
0
16,043
0
0
0
16,083
0
0
0
16,808
0
0
0
17,164
0
0
0
45,578
0
0
0
9,952
0
0
0
5,812
0
0
0
3,657
0
0
0
3,715
0
0
0
29,379
0
0
0
37,186
0
0
0
59,167
0
0
0
138,703
0
0
0
204,522
0
0
0
232,142
166,800
172,400
133,500
231,002
201,800
201,800
201,800201,800231,002133,500172,400166,800232,142000204,522000138,70300059,16700037,18600029,3790003,7150003,6570005,8120009,95200045,57800017,16400016,80800016,08300016,04300018,0410007,3590007,001011,977016,46209,4870
       Other Current Liabilities 
0
35,133
0
100,242
0
61,307
0
41,874
0
0
0
24,196
0
0
0
17,531
27,288
24,227
27,384
23,707
33,291
65,896
43,533
42,409
54,768
56,174
54,108
23,762
39,241
31,759
28,011
21,352
27,588
25,646
26,395
19,997
29,563
40,712
42,906
45,397
72,686
47,125
37,817
25,731
24,408
24,628
19,080
12,795
17,180
16,689
15,270
15,981
15,395
21,587
30,435
97,519
176,135
69,460
86,757
43,751
0
0
0
137,936
0
0
0
39,598
1,290,554
1,337,322
0
95,537
0
4,206,810
0
82,206
3,300
17,000
28,400
63,294
37,400
37,400
37,40037,40063,29428,40017,0003,30082,20604,206,810095,53701,337,3221,290,55439,598000137,93600043,75186,75769,460176,13597,51930,43521,58715,39515,98115,27016,68917,18012,79519,08024,62824,40825,73137,81747,12572,68645,39742,90640,71229,56319,99726,39525,64627,58821,35228,01131,75939,24123,76254,10856,17454,76842,40943,53365,89633,29123,70727,38424,22727,28817,53100024,19600041,874061,3070100,242035,1330
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,018,662
1,990,004
4,211,771
1,720,502
2,687,220
2,600,877
1,627,160
1,657,541
1,633,100
1,572,900
1,534,500
6,192,758
0
9,609,400
9,609,40006,192,7581,534,5001,572,9001,633,1001,657,5411,627,1602,600,8772,687,2201,720,5024,211,7711,990,0042,018,66200000000000000000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,186,712
1,127,803
1,102,700
1,044,400
1,046,700
5,632,600
0
8,625,700
8,625,70005,632,6001,046,7001,044,4001,102,7001,127,8031,186,71200000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
13,939
0
8,078
0
3,355
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
0
0
0
26
21,026
21,026
21,026
26
57,467
55,394
53,464
4,272
83,332
84,654
155,449
147,460
142,980
139,455
447,447
472,119
460,042
451,030
440,449
529,739
530,500
528,500
487,800
560,201
983,700
983,700
983,700983,700560,201487,800528,500530,500529,739440,449451,030460,042472,119447,447139,455142,980147,460155,44984,65483,3324,27253,46455,39457,4672621,02621,02621,026260001800000000000000000000000000000000000000000003,35508,078013,939000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619
0
0
0
909
0
0
0
1,743
0
0
0
5,024
0
0
0
81,867
0
0
0
111,581
0
0
00111,58100081,8670005,0240001,74300090900061900000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,292,038
901,079
708,883
557,683
393,684
269,060
267,547
174,850
141,634
117,348
91,808
178,952
176,500
141,210
109,839
336,548
300,411
275,283
263,516
210,503
159,072
479,492
448,909
394,263
342,424
292,512
250,662
219,474
173,576
136,747
102,543
215,159
174,695
136,205
101,765
342,548
294,851
217,636
166,559
115,922
61,880
39,262
26,622
45,917
35,248
20,666
27,185
23,839
10,461
72,596
62,686
40,907
25,562
24,017
239,545
363,457
366,442
620,524
627,027
716,890
1,104,254
1,061,739
1,074,103
1,586,475
1,876,704
3,657,527
3,650,975
3,610,945
3,704,585
3,713,417
3,698,061
5,640,270
5,590,061
5,642,197
5,627,951
5,638,490
5,782,000
5,820,700
5,884,000
5,814,300
0
8,257,400
8,257,40005,814,3005,884,0005,820,7005,782,0005,638,4905,627,9515,642,1975,590,0615,640,2703,698,0613,713,4173,704,5853,610,9453,650,9753,657,5271,876,7041,586,4751,074,1031,061,7391,104,254716,890627,027620,524366,442363,457239,54524,01725,56240,90762,68672,59610,46123,83927,18520,66635,24845,91726,62239,26261,880115,922166,559217,636294,851342,548101,765136,205174,695215,159102,543136,747173,576219,474250,662292,512342,424394,263448,909479,492159,072210,503263,516275,283300,411336,548109,839141,210176,500178,95291,808117,348141,634174,850267,547269,060393,684557,683708,883901,0791,292,038
   Common Stock
0
59,996
0
60,130
0
60,263
0
84,390
0
0
0
154,825
0
0
61,930
154,826
300,411
275,283
263,516
38,706
159,072
479,492
448,909
58,059
342,424
292,512
250,662
58,059
58,059
58,059
58,059
77,412
77,412
77,412
77,412
191,593
193,532
193,532
193,532
193,532
193,532
7,741
7,741
7,741
9,919
9,919
9,919
9,919
9,919
13,525
13,525
13,525
13,525
13,795
18,787
19,970
19,970
25,562
25,562
25,563
32,866
32,865
1,074,103
32,866
43,822
65,733
3,650,975
65,733
65,733
65,733
65,733
90,013
90,013
90,013
90,013
90,013
90,000
90,000
90,000
90,012
109,300
109,300
109,300109,30090,01290,00090,00090,00090,01390,01390,01390,01390,01365,73365,73365,73365,7333,650,97565,73343,82232,8661,074,10332,86532,86625,56325,56225,56219,97019,97018,78713,79513,52513,52513,52513,5259,9199,9199,9199,9199,9197,7417,7417,741193,532193,532193,532193,532193,532191,59377,41277,41277,41277,41258,05958,05958,05958,059250,662292,512342,42458,059448,909479,492159,07238,706263,516275,283300,411154,82661,93000154,82500084,390060,263060,130059,9960
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,010,261
6,010,261
6,010,261
6,010,261
6,010,261
6,019,300
6,113,800
6,010,300
6,010,261
0
8,484,800
8,484,80006,010,2616,010,3006,113,8006,019,3006,010,2616,010,2616,010,2616,010,2616,010,26100000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11,338
0
377
0
3,643
0
0
0
-460,005
-1
0
-1
-71,641
12,000
-22,300
-17,900
17,688
114,800
114,800
114,800114,80017,688-17,900-22,30012,000-71,641-10-1-460,0050003,64303770-11,338000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.